UBS Group’s RXR Acquisition Corp. Warrants to purchase Class A common stock RXRAW Stock Holding History

UBS Group’s Portfolio RXRAW Stock Details RXRAW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-3,353	Closed	–	–	11655
2022 Q3	$0	Sell	3,353 -1	-0%	–	﹤0.01%	11531
2022 Q2	$0	Hold	3,354	–	–	﹤0.01%	11497
2022 Q1	$2K	Hold	3,354	–	–	﹤0.01%	9778
2021 Q4	$2K	Buy	3,354 +400	+14%	+$301	﹤0.01%	9908
2021 Q3	$2K	Buy	+2,954	New	+$2.73K	﹤0.01%	9070

UBS Group's RXRAW Position: Q4 2022 in Review

UBS Group sold out of RXR Acquisition Corp. Warrants to purchase Class A common stock (RXRAW) in Q4 2022, closing a stake of 3,353 shares.

UBS Group first reported a position in RXRAW in Q3 2021 and held it in 5 quarters. The position peaked at $2K in Q1 2022. 0 funds tracked by Wall St. Rank hold RXRAW as of Q4 2022.

UBS Group reported no remaining RXR Acquisition Corp. Warrants to purchase Class A common stock position as of Q4 2022 after selling out during the quarter.
UBS Group sold 3,353 RXR Acquisition Corp. Warrants to purchase Class A common stock shares in Q4 2022.
UBS Group first reported a position in RXR Acquisition Corp. Warrants to purchase Class A common stock in Q3 2021 and held it in 5 quarters.
UBS Group's RXR Acquisition Corp. Warrants to purchase Class A common stock position peaked at $2K in Q1 2022.
0 funds tracked by Wall St. Rank held RXR Acquisition Corp. Warrants to purchase Class A common stock as of Q4 2022.

Based on UBS Group's 13F filing for Q4 2022, filed 8 Feb 2023.